Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.91967768 |
2 | locomotory exploration behavior (GO:0035641) | 5.90566497 |
3 | synaptic vesicle maturation (GO:0016188) | 5.78808090 |
4 | response to pheromone (GO:0019236) | 5.73526598 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.46335824 |
6 | gamma-aminobutyric acid transport (GO:0015812) | 5.40108508 |
7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.37964633 |
8 | synaptic vesicle exocytosis (GO:0016079) | 5.32295315 |
9 | neurotransmitter secretion (GO:0007269) | 5.26823163 |
10 | cerebellar granule cell differentiation (GO:0021707) | 5.23656021 |
11 | low-density lipoprotein particle clearance (GO:0034383) | 5.21513956 |
12 | vocalization behavior (GO:0071625) | 5.19524336 |
13 | neuronal action potential propagation (GO:0019227) | 5.15775041 |
14 | response to dietary excess (GO:0002021) | 5.11518823 |
15 | glutamate secretion (GO:0014047) | 4.87736967 |
16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.85688252 |
17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.83869225 |
18 | neuron cell-cell adhesion (GO:0007158) | 4.76419933 |
19 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.72586904 |
20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.71327929 |
21 | regulation of synaptic vesicle transport (GO:1902803) | 4.67659882 |
22 | cellular potassium ion homeostasis (GO:0030007) | 4.57081389 |
23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.55649873 |
24 | glutamate receptor signaling pathway (GO:0007215) | 4.47244753 |
25 | neuromuscular process controlling posture (GO:0050884) | 4.44571273 |
26 | regulation of sequestering of triglyceride (GO:0010889) | 4.42736269 |
27 | synaptic transmission, glutamatergic (GO:0035249) | 4.42558637 |
28 | neurotransmitter transport (GO:0006836) | 4.30377698 |
29 | sodium ion export (GO:0071436) | 4.30370018 |
30 | exploration behavior (GO:0035640) | 4.29108568 |
31 | neuron-neuron synaptic transmission (GO:0007270) | 4.28697867 |
32 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.22654226 |
33 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.19593965 |
34 | triglyceride catabolic process (GO:0019433) | 4.14402199 |
35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.13325292 |
36 | layer formation in cerebral cortex (GO:0021819) | 4.11366260 |
37 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.10883570 |
38 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.02432410 |
39 | auditory behavior (GO:0031223) | 4.00519869 |
40 | regulation of neurotransmitter levels (GO:0001505) | 3.99794832 |
41 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.96540453 |
42 | cell differentiation in hindbrain (GO:0021533) | 3.95960666 |
43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.95854883 |
44 | positive regulation of synapse maturation (GO:0090129) | 3.95339667 |
45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.94725836 |
46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.90652231 |
47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.89712022 |
48 | protein localization to synapse (GO:0035418) | 3.88683317 |
49 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.87143662 |
50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.84790263 |
51 | collecting duct development (GO:0072044) | 3.84750691 |
52 | long-term memory (GO:0007616) | 3.79637667 |
53 | acylglycerol catabolic process (GO:0046464) | 3.78799028 |
54 | neutral lipid catabolic process (GO:0046461) | 3.78799028 |
55 | neuronal ion channel clustering (GO:0045161) | 3.77345627 |
56 | positive regulation of vesicle fusion (GO:0031340) | 3.74637566 |
57 | negative regulation of amino acid transport (GO:0051956) | 3.72580667 |
58 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.68580775 |
59 | activation of protein kinase A activity (GO:0034199) | 3.60999759 |
60 | synaptic vesicle endocytosis (GO:0048488) | 3.60337741 |
61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.55133251 |
62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.53608589 |
63 | establishment of mitochondrion localization (GO:0051654) | 3.53484616 |
64 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.53426114 |
65 | adult walking behavior (GO:0007628) | 3.50943316 |
66 | proline transport (GO:0015824) | 3.50825889 |
67 | regulation of gonadotropin secretion (GO:0032276) | 3.49238601 |
68 | dendritic spine morphogenesis (GO:0060997) | 3.47292684 |
69 | detection of calcium ion (GO:0005513) | 3.46909474 |
70 | cell communication by electrical coupling (GO:0010644) | 3.45164283 |
71 | glycine transport (GO:0015816) | 3.43447111 |
72 | regulation of neurotransmitter secretion (GO:0046928) | 3.42667972 |
73 | neuromuscular process controlling balance (GO:0050885) | 3.41567515 |
74 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.40313500 |
75 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.40045275 |
76 | transmission of nerve impulse (GO:0019226) | 3.36424275 |
77 | cell migration in hindbrain (GO:0021535) | 3.34488493 |
78 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.33097062 |
79 | membrane depolarization during action potential (GO:0086010) | 3.32616164 |
80 | potassium ion import (GO:0010107) | 3.32576899 |
81 | potassium ion homeostasis (GO:0055075) | 3.32279328 |
82 | nucleobase catabolic process (GO:0046113) | 3.31457547 |
83 | regulation of synapse structural plasticity (GO:0051823) | 3.30395872 |
84 | positive regulation of membrane potential (GO:0045838) | 3.26782243 |
85 | negative regulation of microtubule polymerization (GO:0031115) | 3.25624479 |
86 | positive regulation of synapse assembly (GO:0051965) | 3.24885985 |
87 | postsynaptic membrane organization (GO:0001941) | 3.24676540 |
88 | regulation of neurotransmitter transport (GO:0051588) | 3.21165176 |
89 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.20364010 |
90 | regulation of postsynaptic membrane potential (GO:0060078) | 3.19729300 |
91 | glycerolipid catabolic process (GO:0046503) | 3.18812412 |
92 | regulation of synapse maturation (GO:0090128) | 3.18142403 |
93 | long-term synaptic potentiation (GO:0060291) | 3.18070143 |
94 | synapse assembly (GO:0007416) | 3.15714414 |
95 | neuron recognition (GO:0008038) | 3.15609110 |
96 | neuromuscular synaptic transmission (GO:0007274) | 3.15016502 |
97 | membrane hyperpolarization (GO:0060081) | 3.14274201 |
98 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.13654172 |
99 | synaptic transmission (GO:0007268) | 3.12693086 |
100 | mating behavior (GO:0007617) | 3.12237225 |
101 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.12217499 |
102 | neuromuscular process (GO:0050905) | 3.11935618 |
103 | acidic amino acid transport (GO:0015800) | 3.11654696 |
104 | regulation of vesicle fusion (GO:0031338) | 3.11532212 |
105 | sympathetic nervous system development (GO:0048485) | 3.11416137 |
106 | cellular response to epinephrine stimulus (GO:0071872) | 3.09867793 |
107 | lipid particle organization (GO:0034389) | 3.08991261 |
108 | protein heterotrimerization (GO:0070208) | 3.07758706 |
109 | positive regulation of dendritic spine development (GO:0060999) | 3.07279771 |
110 | membrane depolarization (GO:0051899) | 3.05883122 |
111 | cerebellar Purkinje cell layer development (GO:0021680) | 3.05867214 |
112 | cellular response to catecholamine stimulus (GO:0071870) | 3.05594137 |
113 | cellular response to monoamine stimulus (GO:0071868) | 3.05594137 |
114 | axon extension (GO:0048675) | 3.05165221 |
115 | behavioral response to ethanol (GO:0048149) | 3.02065891 |
116 | response to auditory stimulus (GO:0010996) | 2.99383345 |
117 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.99206514 |
118 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.98568582 |
119 | righting reflex (GO:0060013) | 2.98026550 |
120 | C4-dicarboxylate transport (GO:0015740) | 2.94793042 |
121 | axonal fasciculation (GO:0007413) | 2.94594405 |
122 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.93871619 |
123 | dendrite morphogenesis (GO:0048813) | 2.92701401 |
124 | L-glutamate transport (GO:0015813) | 2.92614366 |
125 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.91320436 |
126 | vesicle transport along microtubule (GO:0047496) | 2.90599596 |
127 | startle response (GO:0001964) | 2.90259607 |
128 | presynaptic membrane organization (GO:0097090) | 2.89678227 |
129 | glycosphingolipid biosynthetic process (GO:0006688) | 2.89626875 |
130 | social behavior (GO:0035176) | 2.89515976 |
131 | intraspecies interaction between organisms (GO:0051703) | 2.89515976 |
132 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88145091 |
133 | positive regulation of urine volume (GO:0035810) | 2.86293147 |
134 | regulation of protein kinase A signaling (GO:0010738) | 2.81845338 |
135 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.81038583 |
136 | neuron projection extension (GO:1990138) | 2.72645313 |
137 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.72010641 |
138 | mechanosensory behavior (GO:0007638) | 2.71632439 |
139 | dopamine receptor signaling pathway (GO:0007212) | 2.70737144 |
140 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.69313832 |
141 | membrane assembly (GO:0071709) | 2.68094947 |
142 | lipid storage (GO:0019915) | 2.66014045 |
143 | negative regulation of response to food (GO:0032096) | 2.64515127 |
144 | negative regulation of appetite (GO:0032099) | 2.64515127 |
145 | fatty acid homeostasis (GO:0055089) | 2.63461169 |
146 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.61196767 |
147 | triglyceride biosynthetic process (GO:0019432) | 2.61049647 |
148 | presynaptic membrane assembly (GO:0097105) | 2.60676495 |
149 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.59702242 |
150 | clathrin coat assembly (GO:0048268) | 2.59476758 |
151 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.59364170 |
152 | nephron tubule development (GO:0072080) | 2.59025497 |
153 | histone arginine methylation (GO:0034969) | 2.58949447 |
154 | regulation of female receptivity (GO:0045924) | 2.57581882 |
155 | dendritic spine organization (GO:0097061) | 2.54363167 |
156 | regulation of respiratory system process (GO:0044065) | 2.53957756 |
157 | response to monoamine (GO:0071867) | 2.51602931 |
158 | response to catecholamine (GO:0071869) | 2.51602931 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.08549995 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47541656 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.31769087 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27571620 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13938400 |
6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93596227 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.92913961 |
8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.85064575 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.85064575 |
10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65170825 |
11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.62640256 |
12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60437917 |
13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.57607551 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57309555 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55504816 |
16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54425309 |
17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54392587 |
18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.51353220 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50206936 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40644486 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.38728924 |
22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33441638 |
23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.32812401 |
24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32215065 |
25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26228256 |
26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.25168692 |
27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13761874 |
28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.12136596 |
29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.09706958 |
30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90028515 |
31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86587789 |
32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.76528550 |
33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74029049 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69656383 |
35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69652588 |
36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67708752 |
37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64962188 |
38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63707516 |
39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51707687 |
40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51333619 |
41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49802028 |
42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47600563 |
43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43175619 |
44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41596092 |
45 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38534988 |
46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38518080 |
47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38266058 |
48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35949381 |
49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33188873 |
50 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.32967576 |
51 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.32650167 |
52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29795618 |
53 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29383184 |
54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.29120531 |
55 | * AR_19668381_ChIP-Seq_PC3_Human | 1.25192151 |
56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24996874 |
57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.24355931 |
58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23531862 |
59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23244186 |
60 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.22943207 |
61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22815332 |
62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17293760 |
63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17113881 |
64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16063039 |
65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15741051 |
66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14801369 |
67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14646107 |
68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13810740 |
69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13526194 |
70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10515849 |
71 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10504955 |
72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09196180 |
73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08713730 |
74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08348338 |
75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07965925 |
76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06920448 |
77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06811434 |
78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.06449835 |
79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04938126 |
80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03447797 |
81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02534307 |
82 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02240487 |
83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02150516 |
84 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99757332 |
85 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.99589403 |
86 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98864977 |
87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98272668 |
88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96683401 |
89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95775815 |
90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95342525 |
91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95030196 |
92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94257514 |
93 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93852963 |
94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93479513 |
95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93312885 |
96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93150387 |
97 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92342130 |
98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92273108 |
99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92202623 |
100 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.91789296 |
101 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91591700 |
102 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90812090 |
103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90178183 |
104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88987139 |
105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88718300 |
106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88718300 |
107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88034160 |
108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87348131 |
109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86745770 |
110 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85502837 |
111 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.84966282 |
112 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84827376 |
113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.84819742 |
114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84364757 |
115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83214920 |
116 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82801176 |
117 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.82344885 |
118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81688999 |
119 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.81615912 |
120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81590839 |
121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81473018 |
122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79520911 |
123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.79437362 |
124 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.79263732 |
125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79029723 |
126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78788007 |
127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77629874 |
128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76975740 |
129 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.76831536 |
130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76700848 |
131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.76012559 |
132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.74928943 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.17330874 |
2 | MP0009046_muscle_twitch | 4.28443707 |
3 | MP0003880_abnormal_central_pattern | 3.99372709 |
4 | MP0005670_abnormal_white_adipose | 3.93316013 |
5 | * MP0003635_abnormal_synaptic_transmissio | 3.91813358 |
6 | MP0002064_seizures | 3.28881541 |
7 | MP0009745_abnormal_behavioral_response | 3.28005902 |
8 | MP0005423_abnormal_somatic_nervous | 3.12656901 |
9 | * MP0002272_abnormal_nervous_system | 2.92633825 |
10 | MP0002063_abnormal_learning/memory/cond | 2.90855973 |
11 | MP0004270_analgesia | 2.83409433 |
12 | MP0001968_abnormal_touch/_nociception | 2.82790329 |
13 | MP0004130_abnormal_muscle_cell | 2.82542385 |
14 | MP0002572_abnormal_emotion/affect_behav | 2.65067644 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.59218228 |
16 | MP0005666_abnormal_adipose_tissue | 2.53946550 |
17 | MP0008569_lethality_at_weaning | 2.48441194 |
18 | MP0001486_abnormal_startle_reflex | 2.44275794 |
19 | MP0002876_abnormal_thyroid_physiology | 2.38305452 |
20 | MP0002067_abnormal_sensory_capabilities | 2.36280723 |
21 | MP0001501_abnormal_sleep_pattern | 2.30299232 |
22 | MP0002736_abnormal_nociception_after | 2.30064739 |
23 | MP0002184_abnormal_innervation | 2.26305228 |
24 | MP0002735_abnormal_chemical_nociception | 2.19995488 |
25 | MP0001440_abnormal_grooming_behavior | 2.15422163 |
26 | MP0005375_adipose_tissue_phenotype | 2.11587317 |
27 | MP0002971_abnormal_brown_adipose | 2.06367550 |
28 | MP0003122_maternal_imprinting | 2.06365117 |
29 | MP0006276_abnormal_autonomic_nervous | 2.04739556 |
30 | MP0003787_abnormal_imprinting | 2.02573333 |
31 | MP0002733_abnormal_thermal_nociception | 1.92869743 |
32 | MP0001970_abnormal_pain_threshold | 1.89800512 |
33 | MP0004885_abnormal_endolymph | 1.89336064 |
34 | MP0001984_abnormal_olfaction | 1.86045099 |
35 | MP0005551_abnormal_eye_electrophysiolog | 1.85729223 |
36 | MP0002557_abnormal_social/conspecific_i | 1.84756820 |
37 | MP0004142_abnormal_muscle_tone | 1.82881162 |
38 | MP0005386_behavior/neurological_phenoty | 1.76975031 |
39 | MP0004924_abnormal_behavior | 1.76975031 |
40 | MP0003959_abnormal_lean_body | 1.74551555 |
41 | MP0003011_delayed_dark_adaptation | 1.71533048 |
42 | MP0002822_catalepsy | 1.70228038 |
43 | MP0005645_abnormal_hypothalamus_physiol | 1.66743960 |
44 | MP0004811_abnormal_neuron_physiology | 1.64108702 |
45 | MP0003329_amyloid_beta_deposits | 1.64068455 |
46 | MP0009780_abnormal_chondrocyte_physiolo | 1.63774848 |
47 | MP0000003_abnormal_adipose_tissue | 1.62634476 |
48 | MP0000955_abnormal_spinal_cord | 1.59007331 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.56974563 |
50 | MP0004145_abnormal_muscle_electrophysio | 1.54960776 |
51 | MP0002882_abnormal_neuron_morphology | 1.54291906 |
52 | MP0000778_abnormal_nervous_system | 1.54159169 |
53 | MP0001502_abnormal_circadian_rhythm | 1.53775424 |
54 | * MP0002066_abnormal_motor_capabilities/c | 1.52327419 |
55 | MP0006072_abnormal_retinal_apoptosis | 1.50176772 |
56 | MP0002909_abnormal_adrenal_gland | 1.47645889 |
57 | MP0004742_abnormal_vestibular_system | 1.47359880 |
58 | MP0004858_abnormal_nervous_system | 1.47141778 |
59 | MP0003879_abnormal_hair_cell | 1.45366660 |
60 | MP0002229_neurodegeneration | 1.42228749 |
61 | MP0002638_abnormal_pupillary_reflex | 1.36843665 |
62 | MP0005646_abnormal_pituitary_gland | 1.36400164 |
63 | MP0002970_abnormal_white_adipose | 1.35551189 |
64 | MP0009115_abnormal_fat_cell | 1.29578930 |
65 | MP0005394_taste/olfaction_phenotype | 1.27326597 |
66 | MP0005499_abnormal_olfactory_system | 1.27326597 |
67 | MP0003633_abnormal_nervous_system | 1.26181627 |
68 | MP0005334_abnormal_fat_pad | 1.26112948 |
69 | MP0005448_abnormal_energy_balance | 1.24002991 |
70 | MP0003631_nervous_system_phenotype | 1.19283212 |
71 | MP0003632_abnormal_nervous_system | 1.18709246 |
72 | MP0005253_abnormal_eye_physiology | 1.16746899 |
73 | MP0002152_abnormal_brain_morphology | 1.15500239 |
74 | MP0000013_abnormal_adipose_tissue | 1.13125549 |
75 | MP0002752_abnormal_somatic_nervous | 1.04695903 |
76 | MP0003634_abnormal_glial_cell | 1.00367851 |
77 | MP0001529_abnormal_vocalization | 0.99835500 |
78 | MP0004233_abnormal_muscle_weight | 0.98595584 |
79 | MP0001879_abnormal_lymphatic_vessel | 0.98175508 |
80 | MP0008872_abnormal_physiological_respon | 0.98070803 |
81 | MP0005452_abnormal_adipose_tissue | 0.97711554 |
82 | MP0001963_abnormal_hearing_physiology | 0.97363500 |
83 | MP0001905_abnormal_dopamine_level | 0.96986574 |
84 | MP0010329_abnormal_lipoprotein_level | 0.96928982 |
85 | MP0000751_myopathy | 0.96078984 |
86 | MP0002069_abnormal_eating/drinking_beha | 0.92351510 |
87 | MP0003690_abnormal_glial_cell | 0.91393432 |
88 | MP0010368_abnormal_lymphatic_system | 0.89990024 |
89 | MP0006138_congestive_heart_failure | 0.87746536 |
90 | MP0001188_hyperpigmentation | 0.86705573 |
91 | MP0004043_abnormal_pH_regulation | 0.86582554 |
92 | MP0003948_abnormal_gas_homeostasis | 0.86371584 |
93 | MP0005503_abnormal_tendon_morphology | 0.84859453 |
94 | MP0004215_abnormal_myocardial_fiber | 0.84629565 |
95 | MP0001485_abnormal_pinna_reflex | 0.82665978 |
96 | MP0002090_abnormal_vision | 0.81987069 |
97 | MP0004147_increased_porphyrin_level | 0.81814881 |
98 | MP0001299_abnormal_eye_distance/ | 0.81246595 |
99 | MP0003646_muscle_fatigue | 0.80036128 |
100 | MP0000920_abnormal_myelination | 0.79799214 |
101 | MP0003121_genomic_imprinting | 0.79200172 |
102 | MP0002089_abnormal_postnatal_growth/wei | 0.75669634 |
103 | MP0002653_abnormal_ependyma_morphology | 0.75300005 |
104 | MP0004085_abnormal_heartbeat | 0.75179847 |
105 | MP0001177_atelectasis | 0.74787875 |
106 | MP0003283_abnormal_digestive_organ | 0.73767712 |
107 | MP0002118_abnormal_lipid_homeostasis | 0.73549186 |
108 | MP0002332_abnormal_exercise_endurance | 0.73297480 |
109 | MP0008877_abnormal_DNA_methylation | 0.72590339 |
110 | MP0003123_paternal_imprinting | 0.71677859 |
111 | MP0004484_altered_response_of | 0.70380644 |
112 | MP0002837_dystrophic_cardiac_calcinosis | 0.70047811 |
113 | MP0008874_decreased_physiological_sensi | 0.69727473 |
114 | MP0005623_abnormal_meninges_morphology | 0.69239109 |
115 | MP0003137_abnormal_impulse_conducting | 0.67177936 |
116 | MP0002078_abnormal_glucose_homeostasis | 0.66082046 |
117 | MP0000604_amyloidosis | 0.65526289 |
118 | MP0005535_abnormal_body_temperature | 0.65308382 |
119 | MP0000750_abnormal_muscle_regeneration | 0.65091967 |
120 | MP0001881_abnormal_mammary_gland | 0.64823760 |
121 | MP0010386_abnormal_urinary_bladder | 0.64009589 |
122 | MP0005275_abnormal_skin_tensile | 0.63178931 |
123 | MP0002108_abnormal_muscle_morphology | 0.62981271 |
124 | MP0003186_abnormal_redox_activity | 0.62499503 |
125 | MP0005195_abnormal_posterior_eye | 0.60354164 |
126 | MP0001943_abnormal_respiration | 0.60096960 |
127 | MP0010769_abnormal_survival | 0.59229165 |
128 | MP0003183_abnormal_peptide_metabolism | 0.59199771 |
129 | MP0010770_preweaning_lethality | 0.59119858 |
130 | MP0000759_abnormal_skeletal_muscle | 0.57978981 |
131 | MP0005257_abnormal_intraocular_pressure | 0.56908898 |
132 | MP0003953_abnormal_hormone_level | 0.55522197 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.29488309 |
2 | Visual hallucinations (HP:0002367) | 6.00608407 |
3 | Progressive cerebellar ataxia (HP:0002073) | 5.63888512 |
4 | Myokymia (HP:0002411) | 5.46951043 |
5 | Atonic seizures (HP:0010819) | 5.31771867 |
6 | Focal seizures (HP:0007359) | 5.17365010 |
7 | Febrile seizures (HP:0002373) | 4.91960795 |
8 | Action tremor (HP:0002345) | 4.77104736 |
9 | Absence seizures (HP:0002121) | 4.27758856 |
10 | Epileptic encephalopathy (HP:0200134) | 4.17732975 |
11 | Gaze-evoked nystagmus (HP:0000640) | 3.98317878 |
12 | Dysdiadochokinesis (HP:0002075) | 3.80808110 |
13 | Acanthosis nigricans (HP:0000956) | 3.73638823 |
14 | Scanning speech (HP:0002168) | 3.65592720 |
15 | Dialeptic seizures (HP:0011146) | 3.65509187 |
16 | Generalized tonic-clonic seizures (HP:0002069) | 3.65105848 |
17 | Neurofibrillary tangles (HP:0002185) | 3.64600419 |
18 | Truncal ataxia (HP:0002078) | 3.54798819 |
19 | Cerebral inclusion bodies (HP:0100314) | 3.43294939 |
20 | Broad-based gait (HP:0002136) | 3.36574128 |
21 | Hemiplegia (HP:0002301) | 3.28103421 |
22 | Abnormal eating behavior (HP:0100738) | 3.26574776 |
23 | Supranuclear gaze palsy (HP:0000605) | 3.25430577 |
24 | Abnormality of the lower motor neuron (HP:0002366) | 3.17744959 |
25 | Dysmetric saccades (HP:0000641) | 3.17391266 |
26 | Genetic anticipation (HP:0003743) | 3.17236039 |
27 | Pheochromocytoma (HP:0002666) | 3.16561989 |
28 | Depression (HP:0000716) | 3.14497215 |
29 | Impaired smooth pursuit (HP:0007772) | 3.11696996 |
30 | Dysmetria (HP:0001310) | 3.09108611 |
31 | Supernumerary nipples (HP:0002558) | 3.08971409 |
32 | Failure to thrive in infancy (HP:0001531) | 3.04537905 |
33 | Abnormality of binocular vision (HP:0011514) | 3.01051169 |
34 | Diplopia (HP:0000651) | 3.01051169 |
35 | Intention tremor (HP:0002080) | 2.96641649 |
36 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.92610841 |
37 | Mutism (HP:0002300) | 2.90358954 |
38 | Anxiety (HP:0000739) | 2.82785366 |
39 | Ankle clonus (HP:0011448) | 2.80423704 |
40 | Neuroendocrine neoplasm (HP:0100634) | 2.80078967 |
41 | Postural instability (HP:0002172) | 2.79638689 |
42 | Ventricular fibrillation (HP:0001663) | 2.77140721 |
43 | Hyperventilation (HP:0002883) | 2.73100542 |
44 | Hemiparesis (HP:0001269) | 2.70549768 |
45 | Poor eye contact (HP:0000817) | 2.70220300 |
46 | Agitation (HP:0000713) | 2.69411553 |
47 | Horizontal nystagmus (HP:0000666) | 2.68513310 |
48 | Status epilepticus (HP:0002133) | 2.66627096 |
49 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.64497139 |
50 | Polyphagia (HP:0002591) | 2.62719110 |
51 | Impaired social interactions (HP:0000735) | 2.62028038 |
52 | Abnormal social behavior (HP:0012433) | 2.62028038 |
53 | Hypertriglyceridemia (HP:0002155) | 2.58748308 |
54 | Central scotoma (HP:0000603) | 2.58699762 |
55 | Progressive inability to walk (HP:0002505) | 2.57702345 |
56 | Limb dystonia (HP:0002451) | 2.56300668 |
57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.55900537 |
58 | Postural tremor (HP:0002174) | 2.55031657 |
59 | Difficulty running (HP:0009046) | 2.54385132 |
60 | Tetraplegia (HP:0002445) | 2.51895821 |
61 | Long foot (HP:0001833) | 2.50882823 |
62 | Thyroid-stimulating hormone excess (HP:0002925) | 2.45882650 |
63 | Abnormality of the corticospinal tract (HP:0002492) | 2.45056452 |
64 | Back pain (HP:0003418) | 2.44876090 |
65 | Rapidly progressive (HP:0003678) | 2.43938428 |
66 | Abnormality of saccadic eye movements (HP:0000570) | 2.38447720 |
67 | Drooling (HP:0002307) | 2.37324754 |
68 | Excessive salivation (HP:0003781) | 2.37324754 |
69 | Lower limb amyotrophy (HP:0007210) | 2.35389067 |
70 | Abnormality of macular pigmentation (HP:0008002) | 2.33625254 |
71 | Turricephaly (HP:0000262) | 2.33027830 |
72 | Narrow nasal bridge (HP:0000446) | 2.32773115 |
73 | Termporal pattern (HP:0011008) | 2.32527549 |
74 | Insidious onset (HP:0003587) | 2.32527549 |
75 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.31353304 |
76 | Spastic gait (HP:0002064) | 2.31192557 |
77 | Psychosis (HP:0000709) | 2.30051944 |
78 | Abnormal hair whorl (HP:0010721) | 2.29692691 |
79 | Congenital stationary night blindness (HP:0007642) | 2.27526465 |
80 | Insulin resistance (HP:0000855) | 2.25704833 |
81 | Hypoplasia of the brainstem (HP:0002365) | 2.25261819 |
82 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.25261819 |
83 | Broad nasal tip (HP:0000455) | 2.23865281 |
84 | Lower limb muscle weakness (HP:0007340) | 2.22729820 |
85 | Bradykinesia (HP:0002067) | 2.22060967 |
86 | Amyotrophic lateral sclerosis (HP:0007354) | 2.22004211 |
87 | Frequent falls (HP:0002359) | 2.21044334 |
88 | Hyperthyroidism (HP:0000836) | 2.20725172 |
89 | Specific learning disability (HP:0001328) | 2.15535828 |
90 | Gait ataxia (HP:0002066) | 2.14635033 |
91 | Fetal akinesia sequence (HP:0001989) | 2.11296198 |
92 | Distal lower limb amyotrophy (HP:0008944) | 2.10147762 |
93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.09465175 |
94 | Neuronal loss in central nervous system (HP:0002529) | 2.07958843 |
95 | Limb ataxia (HP:0002070) | 2.06858112 |
96 | Urinary urgency (HP:0000012) | 2.06817252 |
97 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.06791617 |
98 | Difficulty climbing stairs (HP:0003551) | 2.05662773 |
99 | Hypoventilation (HP:0002791) | 2.05252415 |
100 | Growth hormone excess (HP:0000845) | 2.04989988 |
101 | Abnormality of the labia minora (HP:0012880) | 2.03926949 |
102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.02576781 |
103 | Gait imbalance (HP:0002141) | 2.00487335 |
104 | Cerebral hypomyelination (HP:0006808) | 2.00023377 |
105 | Diminished motivation (HP:0000745) | 1.97060157 |
106 | Apathy (HP:0000741) | 1.97009123 |
107 | Generalized hypotonia (HP:0001290) | 1.96072420 |
108 | Esotropia (HP:0000565) | 1.95929318 |
109 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.94606549 |
110 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.94098883 |
111 | Menstrual irregularities (HP:0000858) | 1.94014199 |
112 | Amblyopia (HP:0000646) | 1.92876839 |
113 | Epileptiform EEG discharges (HP:0011182) | 1.92876423 |
114 | Hypercortisolism (HP:0001578) | 1.92044707 |
115 | Poor suck (HP:0002033) | 1.91946085 |
116 | EEG with generalized epileptiform discharges (HP:0011198) | 1.91410517 |
117 | Absent speech (HP:0001344) | 1.91091414 |
118 | Neonatal onset (HP:0003623) | 1.90364867 |
119 | Split foot (HP:0001839) | 1.89335904 |
120 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88617552 |
121 | Scotoma (HP:0000575) | 1.88539435 |
122 | Shallow orbits (HP:0000586) | 1.88419119 |
123 | Protruding ear (HP:0000411) | 1.87910084 |
124 | Spinal canal stenosis (HP:0003416) | 1.87665226 |
125 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87041307 |
126 | Hypsarrhythmia (HP:0002521) | 1.87024546 |
127 | Upper limb amyotrophy (HP:0009129) | 1.86541332 |
128 | Distal upper limb amyotrophy (HP:0007149) | 1.86541332 |
129 | Blue irides (HP:0000635) | 1.86360191 |
130 | Delusions (HP:0000746) | 1.86262053 |
131 | Oligomenorrhea (HP:0000876) | 1.85823350 |
132 | Clonus (HP:0002169) | 1.84360833 |
133 | Aplasia involving bones of the extremities (HP:0009825) | 1.84213983 |
134 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.84213983 |
135 | Aplasia of the phalanges of the hand (HP:0009802) | 1.84213983 |
136 | Torticollis (HP:0000473) | 1.82295054 |
137 | Ulnar claw (HP:0001178) | 1.80930261 |
138 | Delayed gross motor development (HP:0002194) | 1.80208144 |
139 | Spastic tetraplegia (HP:0002510) | 1.80117520 |
140 | Rigidity (HP:0002063) | 1.79582566 |
141 | Myotonia (HP:0002486) | 1.79219625 |
142 | Focal dystonia (HP:0004373) | 1.77035429 |
143 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.76335336 |
144 | Insomnia (HP:0100785) | 1.74668526 |
145 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.72099335 |
146 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.72099335 |
147 | Pachygyria (HP:0001302) | 1.68570967 |
148 | Protrusio acetabuli (HP:0003179) | 1.68058508 |
149 | Hammertoe (HP:0001765) | 1.67191197 |
150 | Shoulder girdle muscle weakness (HP:0003547) | 1.66100393 |
151 | Atrophic scars (HP:0001075) | 1.65344169 |
152 | Craniofacial dystonia (HP:0012179) | 1.63015534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.88380319 |
2 | MAP3K4 | 3.46035209 |
3 | TESK1 | 2.99355830 |
4 | MINK1 | 2.98147172 |
5 | MAP2K7 | 2.96529441 |
6 | CASK | 2.81125253 |
7 | MAP3K12 | 2.80589285 |
8 | MARK1 | 2.78098169 |
9 | MAP3K9 | 2.77802565 |
10 | NTRK2 | 2.69631844 |
11 | MAP2K4 | 2.46509393 |
12 | EPHB2 | 2.31485481 |
13 | CAMKK2 | 2.23255761 |
14 | MAP3K6 | 2.17000569 |
15 | PAK6 | 1.98813325 |
16 | CDK19 | 1.92764886 |
17 | GRK5 | 1.89694879 |
18 | CAMKK1 | 1.89476275 |
19 | PLK2 | 1.77948828 |
20 | EPHA2 | 1.76663708 |
21 | SIK1 | 1.76250675 |
22 | STK38 | 1.74418554 |
23 | WNK1 | 1.62381411 |
24 | RIPK1 | 1.59131704 |
25 | PRKCG | 1.58599645 |
26 | DAPK2 | 1.55034628 |
27 | CAMK1D | 1.50770758 |
28 | MAPK13 | 1.42878965 |
29 | UHMK1 | 1.42553071 |
30 | SGK494 | 1.41118790 |
31 | SGK223 | 1.41118790 |
32 | TRIB3 | 1.40188417 |
33 | PHKG1 | 1.39338790 |
34 | PHKG2 | 1.39338790 |
35 | AKT3 | 1.38058574 |
36 | PRPF4B | 1.37862243 |
37 | SGK2 | 1.31527795 |
38 | SIK2 | 1.31334988 |
39 | PNCK | 1.30752736 |
40 | CDK5 | 1.30196509 |
41 | ERBB4 | 1.30168868 |
42 | PINK1 | 1.22963946 |
43 | DDR2 | 1.22338583 |
44 | MST1R | 1.17774330 |
45 | SGK3 | 1.13791430 |
46 | PRKCH | 1.12934419 |
47 | ARAF | 1.10142331 |
48 | ABL2 | 1.08508924 |
49 | DYRK2 | 1.08228160 |
50 | DAPK1 | 1.06791613 |
51 | OXSR1 | 1.05464595 |
52 | WNK3 | 1.04279485 |
53 | NTRK1 | 1.01874100 |
54 | CAMK2G | 0.97409901 |
55 | ALK | 0.95686053 |
56 | LMTK2 | 0.95568349 |
57 | CAMK2A | 0.94749866 |
58 | TNIK | 0.94232715 |
59 | TYRO3 | 0.94002480 |
60 | CDK18 | 0.93299381 |
61 | PTK2 | 0.93128578 |
62 | MARK2 | 0.92769872 |
63 | NEK1 | 0.92045672 |
64 | CAMK2B | 0.91726185 |
65 | CDK15 | 0.91590339 |
66 | CDK14 | 0.90548711 |
67 | LIMK1 | 0.84868944 |
68 | STK11 | 0.83843894 |
69 | KSR1 | 0.82886957 |
70 | KSR2 | 0.82648744 |
71 | DYRK1A | 0.82522451 |
72 | ERBB3 | 0.82446961 |
73 | CAMK1 | 0.82438644 |
74 | MAPKAPK5 | 0.81776425 |
75 | RIPK4 | 0.81384284 |
76 | CAMK2D | 0.80135173 |
77 | TSSK6 | 0.79666482 |
78 | CDK11A | 0.79396020 |
79 | ICK | 0.78024692 |
80 | CSNK1G2 | 0.77794517 |
81 | TNK2 | 0.75712099 |
82 | SCYL2 | 0.74893900 |
83 | SIK3 | 0.69475722 |
84 | MAPK12 | 0.67706935 |
85 | PDGFRA | 0.67198904 |
86 | CDC42BPA | 0.65704118 |
87 | RET | 0.65621647 |
88 | MET | 0.64806249 |
89 | FES | 0.64279489 |
90 | LATS2 | 0.64147645 |
91 | TRIM28 | 0.63769416 |
92 | TESK2 | 0.62991316 |
93 | PIM2 | 0.62881475 |
94 | CAMK1G | 0.61834698 |
95 | STK38L | 0.60341305 |
96 | PAK3 | 0.60310404 |
97 | PRKCE | 0.59974558 |
98 | CAMK4 | 0.59444634 |
99 | PRKD3 | 0.58277340 |
100 | PDK1 | 0.56683213 |
101 | SGK1 | 0.55218588 |
102 | RPS6KA3 | 0.55064268 |
103 | ROCK2 | 0.53243215 |
104 | MAPK4 | 0.52858598 |
105 | FER | 0.52686643 |
106 | BCR | 0.51425396 |
107 | MUSK | 0.50945705 |
108 | EPHB1 | 0.50753897 |
109 | PDPK1 | 0.50335096 |
110 | BRAF | 0.49684566 |
111 | TIE1 | 0.49467156 |
112 | PRKD2 | 0.48726319 |
113 | EPHA4 | 0.48654039 |
114 | GRK1 | 0.48628268 |
115 | RPS6KA2 | 0.47931100 |
116 | PRKCZ | 0.47490205 |
117 | MOS | 0.46789872 |
118 | CSNK1G3 | 0.46769144 |
119 | NME1 | 0.45939703 |
120 | PRKAA2 | 0.45238261 |
121 | LATS1 | 0.42551796 |
122 | PRKCB | 0.41905454 |
123 | MAPK10 | 0.41569249 |
124 | FYN | 0.41453937 |
125 | MAP4K2 | 0.41427164 |
126 | PKN1 | 0.41318245 |
127 | ADRBK1 | 0.41192911 |
128 | PRKAA1 | 0.41106417 |
129 | PRKACA | 0.39740280 |
130 | GRK7 | 0.39731182 |
131 | STK39 | 0.39559962 |
132 | RPS6KB1 | 0.39229666 |
133 | CSNK1A1L | 0.38927135 |
134 | MAP3K2 | 0.38368271 |
135 | IRAK3 | 0.35295450 |
136 | PRKACG | 0.32949709 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.36468582 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.88175153 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.13920837 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.86843176 |
5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.71600157 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60267572 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56599662 |
8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.51548982 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.50622805 |
10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.44254624 |
11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26024002 |
12 | Phototransduction_Homo sapiens_hsa04744 | 2.17660570 |
13 | Long-term depression_Homo sapiens_hsa04730 | 2.15331712 |
14 | Taste transduction_Homo sapiens_hsa04742 | 2.13461994 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.07854482 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05408409 |
17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02370438 |
18 | Salivary secretion_Homo sapiens_hsa04970 | 1.92560634 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85822610 |
20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.84951770 |
21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.79960084 |
22 | Insulin secretion_Homo sapiens_hsa04911 | 1.75490128 |
23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72268846 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71851324 |
25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.69093527 |
26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64970699 |
27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54989802 |
28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52241402 |
29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.45679765 |
30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45594828 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44928425 |
32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41544006 |
33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.35636035 |
34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30230070 |
35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.28235772 |
36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27353684 |
37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27188437 |
38 | Renin secretion_Homo sapiens_hsa04924 | 1.25968901 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21300244 |
40 | Gap junction_Homo sapiens_hsa04540 | 1.20924843 |
41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15709177 |
42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12889778 |
43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11233275 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09933815 |
45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08453414 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07616609 |
47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.07426918 |
48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06853597 |
49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03530065 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02722036 |
51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02256083 |
52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98904113 |
53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97216477 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95311309 |
55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94710906 |
56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93936094 |
57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90266938 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86312877 |
59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84800322 |
60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84677343 |
61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82205941 |
62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82035097 |
63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81785637 |
64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78391492 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75748233 |
66 | Glioma_Homo sapiens_hsa05214 | 0.71570006 |
67 | Melanogenesis_Homo sapiens_hsa04916 | 0.70928050 |
68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69690172 |
69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69379761 |
70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68092727 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65768032 |
72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65365714 |
73 | Axon guidance_Homo sapiens_hsa04360 | 0.65323406 |
74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63767318 |
75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63280033 |
76 | Bile secretion_Homo sapiens_hsa04976 | 0.62542001 |
77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61807842 |
78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61039814 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58920337 |
80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58646235 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57872663 |
82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56923173 |
83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56702688 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56345907 |
85 | Alcoholism_Homo sapiens_hsa05034 | 0.56070362 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50738109 |
87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49675362 |
88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49441711 |
89 | Tight junction_Homo sapiens_hsa04530 | 0.49241715 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48753272 |
91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47213621 |
92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46586332 |
93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45328742 |
94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43419647 |
95 | Focal adhesion_Homo sapiens_hsa04510 | 0.43227407 |
96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43178653 |
97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42778172 |
98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42565596 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42456098 |
100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41922042 |
101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41757830 |
102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40417658 |
103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40276511 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.39424947 |
105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38945108 |
106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38847715 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38400482 |
108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38338920 |
109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37793867 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.37595080 |
111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37560627 |
112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37526569 |
113 | Phagosome_Homo sapiens_hsa04145 | 0.36780392 |
114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36556888 |
115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36345687 |
116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36309572 |
117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35257686 |
118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31693881 |
119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31661241 |
120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31521100 |
121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29322911 |
122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28498520 |
123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26993404 |
124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26716010 |
125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.25653433 |
126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24945724 |
127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24100286 |
128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23668410 |
129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23581174 |